Principal Scientist
Amgen
Thousand Oaks, California
Twinkle Christian is a Principal Scientist and team lead in Process Development at Amgen. Prior to joining Amgen, Twinkle worked at VaxGen and Alza where she focused on vaccine product development and alternate drug delivery of biologics, respectively. Twinkle has 20 years of experience in drug product development across diverse modalities and has led the advancement of multiple programs from early discovery to clinical trials and commercialization. She has worked on approved Amgen products including Repatha and Evenity. Twinkle’s expertise encompasses high concentration and ultra-high concentration product development, alternate drug delivery of biologics, investigating protein-protein interactions, and macromolecular crystallography for structure and formulation. Twinkle is a recognized SME in biologics formulation and drug delivery with peer reviewed publications, 6 granted US patents, 35+ patent applications and invited speaker at national and international conferences. Twinkle is an active member of scientific societies and currently serves as a reviewer for J. Pharm. Sci, Chair of AAPS Pharmaceutical Discovery and Preclinical Development community, Co-chair of IQ consortium High Concentration Product Development working group, past co-chair of the IQ consortium Closed System Transfer Devices working group. Twinkle is an adjunct faculty at California State University, Channel Islands, and a guest lecturer at UCSB.
Hot Topic: Challenges and Opportunities of in vitro Assays and Organ-On-A-Chip
Wednesday, October 25, 2023
10:00 AM – 11:00 AM ET